Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-02 Sale | 2022-06-03 4:13 pm | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 1,355 | $0.06 | $81 | 75,388 (Direct) | View |
| 2022-06-02 Sale | 2022-06-03 4:12 pm | GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer | 1,578 | $0.06 | $95 | 89,027 (Direct) | View |
| 2022-06-02 Sale | 2022-06-03 4:11 pm | GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO | 4,023 | $0.06 | $241 | 304,377 (Direct) | View |
| 2022-06-01 Sale | 2022-06-02 4:32 pm | GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF | 2,500 | $0.0601 | $150 | 43,000 (Direct) | View |
| 2022-05-31 Sale | 2022-06-02 4:31 pm | GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO | 117,244 | $0.0617 | $7,234 | 308,400 (Direct) | View |
| 2022-05-27 Sale | 2022-06-01 4:11 pm | GENOCEA BIOSCIENCES INC. | GNCA | Siber George Director | 20,425 | $0.0653 | $1,334 | 252 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 6:32 pm | GENOCEA BIOSCIENCES INC. | GNCA | Walker Paul Edward 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-05-24 Sale | 2022-05-26 6:31 pm | GENOCEA BIOSCIENCES INC. | GNCA | Sonsini Peter W. 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-05-24 Sale | 2022-05-26 6:29 pm | GENOCEA BIOSCIENCES INC. | GNCA | SANDELL SCOTT D 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-05-24 Sale | 2022-05-26 6:26 pm | GENOCEA BIOSCIENCES INC. | GNCA | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Direct) | View |
| 2022-05-24 Sale | 2022-05-26 6:25 pm | GENOCEA BIOSCIENCES INC. | GNCA | Makhzoumi Mohamad 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-05-24 Sale | 2022-05-26 6:23 pm | GENOCEA BIOSCIENCES INC. | GNCA | Florence Anthony A. Jr. 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-05-24 Sale | 2022-05-26 6:21 pm | GENOCEA BIOSCIENCES INC. | GNCA | Chang Carmen 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-05-24 Sale | 2022-05-26 6:19 pm | GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-05-24 Sale | 2022-05-26 6:16 pm | GENOCEA BIOSCIENCES INC. | GNCA | BASKETT FOREST 10% Owner | 10,376,936 | $0.07234 | $750,662 | 0 (Indirect) | View |
| 2022-05-25 Sale | 2022-05-26 4:15 pm | GENOCEA BIOSCIENCES INC. | GNCA | STAPLETON RAYMOND D JR CHIEF TECHNOLOGY OFFICER | 2,500 | $0.089 | $223 | 43,750 (Direct) | View |
| 2022-05-25 Sale | 2022-05-26 4:13 pm | GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer | 16,525 | $0.0881 | $1,456 | 90,605 (Direct) | View |
| 2022-05-26 Sale | 2022-05-26 4:11 pm | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 24,407 | $0.0765 | $1,867 | 76,743 (Direct) | View |
| 2022-04-04 Sale | 2022-04-05 08:18 am | GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer | 1,212 | $1.25 | $1,515 | 96,193 (Direct) | View |
| 2022-04-04 Sale | 2022-04-05 08:17 am | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 963 | $1.25 | $1,204 | 91,775 (Direct) | View |
| 2022-04-04 Sale | 2022-04-05 08:17 am | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 1,091 | $1.25 | $1,364 | 68,330 (Direct) | View |
| 2022-04-04 Sale | 2022-04-05 08:15 am | GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO | 3,924 | $1.25 | $4,905 | 369,487 (Direct) | View |
| 2022-04-04 Sale | 2022-04-05 08:13 am | GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER | 963 | $1.25 | $1,204 | 74,459 (Direct) | View |
| 2022-03-16 Sale | 2022-03-17 4:12 pm | GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer | 3,349 | $1.1 | $3,684 | 228,655 (Direct) | View |
| 2022-03-16 Sale | 2022-03-17 4:11 pm | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 2,873 | $1.1 | $3,160 | 205,238 (Direct) | View |
| 2022-03-16 Sale | 2022-03-17 4:09 pm | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 2,717 | $1.1 | $2,989 | 163,171 (Direct) | View |
| 2022-03-16 Sale | 2022-03-17 4:06 pm | GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO | 11,435 | $1.1 | $12,579 | 823,411 (Direct) | View |
| 2022-03-16 Sale | 2022-03-17 4:04 pm | GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER | 2,397 | $1.1 | $2,637 | 169,172 (Direct) | View |
| 2021-04-02 Sale | 2022-03-16 5:32 pm | GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer | 1,809 | $2.5394 | $4,594 | 67,941 (Direct) | View |
| 2021-04-02 Sale | 2022-03-16 5:31 pm | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 1,436 | $2.5392 | $3,646 | 62,486 (Direct) | View |
| 2021-04-02 Sale | 2022-03-16 5:29 pm | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 1,472 | $2.5391 | $3,738 | 48,700 (Direct) | View |
| 2021-04-02 Sale | 2022-03-16 5:28 pm | GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO | 5,874 | $2.54 | $14,920 | 286,003 (Direct) | View |
| 2021-04-02 Sale | 2022-03-16 5:25 pm | GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER | 1,436 | $2.5392 | $3,646 | 51,881 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-15 Option Award | 2022-03-17 4:17 pm | N/A 2022-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | SUMER JACQUELYN L CHIEF LEGAL & COMPLIANCE OFF | 150,000 | $0 | 158,000 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 4:14 pm | N/A 2032-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | STAPLETON RAYMOND D JR CHIEF TECHNOLOGY OFFICER | 175,000 | $0 | 177,500 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 4:12 pm | N/A 2032-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Flechtner Jessica Baker Chief Scientific Officer | 175,000 | $0 | 228,655 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 4:11 pm | N/A 2032-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER | 150,000 | $0 | 205,238 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 4:09 pm | N/A 2032-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER | 125,000 | $0 | 163,171 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 4:06 pm | N/A 2032-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Clark William D President and CEO | 600,000 | $0 | 823,411 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 4:04 pm | N/A 2032-03-15 | GENOCEA BIOSCIENCES INC. | GNCA | Aakalu Girish N CHIEF BUSINESS OFFICER | 125,000 | $0 | 169,172 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 6:14 pm | N/A 2032-03-03 | GENOCEA BIOSCIENCES INC. | GNCA | Lunger John Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-28 4:02 pm | N/A 2031-09-09 | GENOCEA BIOSCIENCES INC. | GNCA | Herron Jennifer Lyn Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 4:27 pm | 2022-07-01 2031-07-01 | GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |